PK

Pawan Kumar Gaur

Active Director Additional Director DIN 11425292
DIN 11425292 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pawan Kumar Gaur

Data last updated:

Pawan Kumar Gaur is an Additional Director at Alvia Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11425292
Primary Designation Additional Director
Industry Pharma
First Appointment 13 Dec 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director13 Dec 20252025Active

Directorship timeline

Open interactive timeline →
Alvia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar Gaur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar Gaur

Pawan Kumar Gaur currently holds 1 directorship: Alvia Pharmaceuticals Private Limited (Additional Director, since 13 Dec 2025).

Pawan Kumar Gaur was first appointed on 13 Dec 2025 as Additional Director at Alvia Pharmaceuticals Private Limited.

The current boards of Pawan Kumar Gaur's companies include Anju (Alvia Pharmaceuticals Private Limited), Archana Gaur (Alvia Pharmaceuticals Private Limited), Mayank Kumar Singh (Alvia Pharmaceuticals Private Limited), Ranjeet Mukherjee (Alvia Pharmaceuticals Private Limited), Shalu Mukherjee (Alvia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available